Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Sermonix Pharmaceuticals

Sermonix Pharmaceuticals?uq=3Oe4kK1Z
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Seed LATEST DEAL TYPE
$4.2M LATEST DEAL AMOUNT
2 INVESTORS
Description

Operator of a specialty pharmaceutical company intended to develop and commercialize female-specific oncology products. The company's products are used for women's health, menopause and selective estrogen receptor modulators, enabling cancer patients to get high quality oncology products through proof of concept, clinical development and regulatory approval.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Drug Discovery
Primary Office
  • 3000 East Main Street
  • Suite 218
  • Columbus, OH 43209
  • United States

+1 (614) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Sermonix Pharmaceuticals’s full profile, request a free trial.

Sermonix Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 28-Nov-2017 $4.2M 00.00 Completed Startup
2. Seed Round 10-Nov-2016 000 00.00 Completed Startup
1. Convertible Debt 14-Oct-2015 $1.7M $1.7M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Sermonix Pharmaceuticals Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Richard DeSchutter Angel (individual) Minority 000 0000 000000 0
Anthony Wild Angel (individual) Minority 000 0000 000000 0

Sermonix Pharmaceuticals Executive Team (3)

Name Title Board
Seat
Contact
Info
David Portman MD Founder, Chief Executive Officer, Chief Medical Officer & Board Member
Miriam Portman MD Chief Operating Officer & Board Member
Barry Komm Ph.D Chief Scientific Officer

Sermonix Pharmaceuticals Board Members (3)

Name Representing Role Since Contact
Info
Anthony Wild Ph.D Sermonix Pharmaceuticals Chairman & Investor 000 0000
David Portman MD Sermonix Pharmaceuticals Founder, Chief Executive Officer, Chief Medical Officer & Board Member 000 0000
Miriam Portman MD Sermonix Pharmaceuticals Chief Operating Officer & Board Member 000 0000